Ivermectin, fenbendazole and mebendazole for cancer: what the evidence shows

People ask me about ivermectin and fenbendazole all the time. So I went through the human studies. These drugs are a legitimate research idea. They are not proven cancer treatments. Here's what the evidence actually shows.

People bring up ivermectin and fenbendazole with me all the time. So I did what I do with every option for my own cancer: I went to the actual studies and data.

My cancer is driven by a single gene change called an ALK fusion. I'm on the third generation of a pill that targets it, and that pill is the reason I'm still here. So the question I ask about any option is simple: what does the human evidence show?

The short version

Ivermectin is a legitimate research idea. It is not a proven cancer treatment.

Both of those are true at the same time.

Why people believe it

The interest has real roots:

  • Ivermectin is FDA approved for certain parasitic infections in people, and it's cheap and generic.
  • Ivermectin and fenbendazole have shown anticancer effects in lab and animal studies.
  • Generic drugs nobody can patent tend to get less research money.

That last one is real. But "nobody's paying to test it" is a very different claim from "it works and they're hiding it." There's evidence for the first. I haven't found any for the second.

Fenbendazole is different from ivermectin in one important way: it's a veterinary drug and isn't approved for use in people.

What the human evidence shows

The best ivermectin trial so far

A small phase 1/2 trial paired ivermectin with an immunotherapy drug in metastatic triple-negative breast cancer. The patients had already been through a median of 5 prior treatments. Of 8 patients who could be evaluated, 1 tumor shrank, 1 held stable and 6 progressed. The combination was well tolerated. There's no control group, and so far the results are a conference abstract from May 2025. You can't tell what ivermectin added.

The biggest "real-world" study

This one followed 197 patients prescribed ivermectin plus mebendazole through a telemedicine service and reported glowing results. It was retracted in October 2026. Outcomes came from self-reported surveys, only 122 people completed follow-up, and many were also getting chemo, radiation, surgery or supplements at the same time. The journal said methodological problems undermined its central conclusions.

The melanoma case people share

A 74-year-old man with metastatic melanoma declined standard treatment and took veterinary ivermectin paste, fenbendazole and several other over-the-counter products. His blood tumor marker dropped, then rose again, and a lymph node mass later grew. His doctors wrote that his own immune system clearing the cancer is at least as plausible an explanation as anything he took.

The one human mebendazole trial

Mebendazole is a close cousin of fenbendazole. In a small trial in advanced gastrointestinal cancer, every patient who was treated stopped because their cancer progressed. The trial was planned for 30 patients and stopped early after 11 enrolled. The drug was well tolerated, but it had no anticancer effect.

So far, ivermectin's cancer benefit is unproven, and so is fenbendazole's.

The dose problem

In the lab, these drugs work at concentrations far higher than people reach on approved doses. ASCO, the main US group of cancer doctors, says reaching those levels in humans would likely take doses far beyond established safety limits.

"Safe" also has a footnote. ASCO warns that high doses of ivermectin can cause loss of coordination, seizures, coma, dangerously low blood pressure and even death. Veterinary products aren't regulated for human use. Both drugs are processed by liver enzymes that can change how cancer drugs work. And fenbendazole has been linked to liver injury in published case reports.

What about the success stories?

If someone took only ivermectin and beat cancer, that's amazing and I'd celebrate it.

But look closely at most stories. They're stacked: ivermectin plus fenbendazole plus supplements plus surgery or chemo. When five things happen at once, you can't credit one of them.

I can believe someone's improvement is real without knowing what caused it. That doesn't make the patient a liar. It makes the drug's contribution uncertain.

What's actually being tested

  • A University of Florida phase 2 trial will test ivermectin with immunotherapy in solid tumors. It's planned for 80 patients and wasn't yet recruiting as of its October 2026 update. That's how you find out.
  • The breast cancer trial above is still listed as recruiting.

Meanwhile, in May 2026, ASCO recommended against using ivermectin or fenbendazole for cancer, or alongside cancer treatment, outside a clinical trial.

If you're curious, a trial is the safe way to try it. You can search ClinicalTrials.gov for ivermectin, and here's how I look for trials.

Why I'm not taking it

I'm not against ivermectin. I'm for evidence.

I have dozens of options with at least some human data behind them: next-generation targeted drugs, personalized vaccines, antibody-drug conjugates and cell therapies. I track them all.

If every one of those ran out and I had nothing left? Sure, I'd consider it as a Hail Mary. Anyone would.

Until then, the question isn't "is it being suppressed?" The question is "will a real trial show it works at a dose people can safely take?"

I hope the answer is yes. Let's run the trials and find out.

Before you take anything

Talk to your oncologist first. Tell them about everything you take, including supplements and anything bought online or meant for animals. Questions worth asking:

  1. Could this interact with my current treatment?
  2. Is there a clinical trial testing it that I could join?
  3. What would we watch for, and how would we know if it's causing harm?
  4. What proven options do I still have?

I'm not a doctor and this isn't medical advice. It's what happened to me. Please talk to your care team before you change anything.

What would you add?

Help make this page more useful.

I’ll use your email to follow up about your idea. Please don’t include private medical information.